Mechanism-based combination telomerase inhibition therapy
- 31 January 2005
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 7 (1) , 1-2
- https://doi.org/10.1016/j.ccr.2004.12.012
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tankyrase 1 as a target for telomere-directed molecular cancer therapeuticsCancer Cell, 2005
- Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric ProteinsJournal of Biological Chemistry, 2004
- A Dynamic Molecular Link between the Telomere Length Regulator TRF1 and the Chromosome End Protector TRF2Current Biology, 2004
- Telomerase: A target for cancer therapeuticsCancer Cell, 2002
- Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell deathProceedings of the National Academy of Sciences, 1999
- Inhibition of telomerase limits the growth of human cancer cellsNature Medicine, 1999
- Tankyrase, a Poly(ADP-Ribose) Polymerase at Human TelomeresScience, 1998
- A survey of telomerase activity in human cancerPublished by Elsevier ,1997
- Control of telomere length by the human telomeric protein TRF1Nature, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994